Jennifer L Steel1,2,3, David A Geller2, Kevin H Kim2, Lisa H Butterfield4, Michael Spring5, Jonathan Grady5, Weiing Sun6, Wallis Marsh2, Michael Antoni7, Mary Amanda Dew8, Vicki Helgeson9, Richard Schulz3, Allan Tsung2. 1. Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 2. Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania. 3. Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania. 4. Departments of Medicine, Surgery and Immunology, Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. 5. School of Information Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania. 6. Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania. 7. Department of Psychology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida. 8. Departments of Psychiatry, Psychology, Epidemiology, Biostatistics, and Clinical and Translational Science, University of Pittsburgh, Pittsburgh, Pennsylvania. 9. Department of Psychology, Carnegie Mellon University, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND: The aim of this study was to examine the efficacy of a collaborative care intervention in reducing depression, pain, and fatigue and improve quality of life. METHODS: A total of 261 patients with advanced cancer and 179 family caregivers were randomized to a web-based collaborative care intervention or enhanced usual care. The intervention included the following: 1) a web site with written and audiovisual self-management strategies, a bulletin board, and other resources; 2) visits with a care coordinator during a physician's appointment every 2 months; and 3) telephone follow-up every 2 weeks. Primary patient outcomes included measures of depression, pain, fatigue, and health-related quality of life. Secondary outcomes included Interleukin (IL)-1α, IL-1β, IL-6, and IL-8 levels, Natural Killer (NK) cell numbers, and caregiver stress and depression. RESULTS: At the baseline, 51% of the patients reported 1 or more symptoms in the clinical range. For patients who presented with clinical levels of symptoms and were randomized to the intervention, reductions in depression (Cohen's d = 0.71), pain (Cohen's d = 0.62), and fatigue (Cohen's d = 0.26) and improvements in quality of life (Cohen's d = 0.99) were observed when compared to those in the enhanced usual car arm at 6 months. Reductions in IL-6 (φ = 0.18), IL-1β (φ = 0.35), IL-1α (φ = 0.19), and IL-8 (φ = 0.15) and increases in NK cell numbers (φ = 0.23) were observed in comparison with enhanced usual care arm at 6 months. Reductions in caregiver stress (Cohen's d = 0.75) and depression (Cohen's d = 0.37) were observed at 6 months for caregivers whose loved ones were randomized to the intervention arm. CONCLUSIONS: The integration of screening and symptom management into cancer care is recommended.
RCT Entities:
BACKGROUND: The aim of this study was to examine the efficacy of a collaborative care intervention in reducing depression, pain, and fatigue and improve quality of life. METHODS: A total of 261 patients with advanced cancer and 179 family caregivers were randomized to a web-based collaborative care intervention or enhanced usual care. The intervention included the following: 1) a web site with written and audiovisual self-management strategies, a bulletin board, and other resources; 2) visits with a care coordinator during a physician's appointment every 2 months; and 3) telephone follow-up every 2 weeks. Primary patient outcomes included measures of depression, pain, fatigue, and health-related quality of life. Secondary outcomes included Interleukin (IL)-1α, IL-1β, IL-6, and IL-8 levels, Natural Killer (NK) cell numbers, and caregiver stress and depression. RESULTS: At the baseline, 51% of the patients reported 1 or more symptoms in the clinical range. For patients who presented with clinical levels of symptoms and were randomized to the intervention, reductions in depression (Cohen's d = 0.71), pain (Cohen's d = 0.62), and fatigue (Cohen's d = 0.26) and improvements in quality of life (Cohen's d = 0.99) were observed when compared to those in the enhanced usual car arm at 6 months. Reductions in IL-6 (φ = 0.18), IL-1β (φ = 0.35), IL-1α (φ = 0.19), and IL-8 (φ = 0.15) and increases in NK cell numbers (φ = 0.23) were observed in comparison with enhanced usual care arm at 6 months. Reductions in caregiver stress (Cohen's d = 0.75) and depression (Cohen's d = 0.37) were observed at 6 months for caregivers whose loved ones were randomized to the intervention arm. CONCLUSIONS: The integration of screening and symptom management into cancer care is recommended.
Authors: Ron N Apte; Shahar Dotan; Moshe Elkabets; Malka R White; Eli Reich; Yaron Carmi; Xiaping Song; Tatyana Dvozkin; Yakov Krelin; Elena Voronov Journal: Cancer Metastasis Rev Date: 2006-09 Impact factor: 9.264
Authors: Kathryn C Dickinson; Rajiv Sharma; Jonathan P Duckart; Kathryn Corson; Martha S Gerrity; Steven K Dobscha Journal: Med Care Date: 2010-01 Impact factor: 2.983
Authors: Karen L Syrjala; Jean C Yi; Samantha B Artherholt; Joan M Romano; Marie-Laure Crouch; Allison S Fiscalini; Mark T Hegel; Mary E D Flowers; Paul J Martin; Wendy M Leisenring Journal: J Cancer Surviv Date: 2018-05-05 Impact factor: 4.442
Authors: Jennifer L Steel; Lauren Terhorst; Kevin P Collins; David A Geller; Yoram Vodovotz; Juliana Kim; Andrew Krane; Michael Antoni; James W Marsh; Lora E Burke; Lisa H Butterfield; Frank J Penedo; Daniel J Buysse; Allan Tsung Journal: Psychosom Med Date: 2018-06 Impact factor: 4.312
Authors: Dio Kavalieratos; Jennifer Corbelli; Di Zhang; J Nicholas Dionne-Odom; Natalie C Ernecoff; Janel Hanmer; Zachariah P Hoydich; Dara Z Ikejiani; Michele Klein-Fedyshin; Camilla Zimmermann; Sally C Morton; Robert M Arnold; Lucas Heller; Yael Schenker Journal: JAMA Date: 2016-11-22 Impact factor: 56.272
Authors: Natalie C Ernecoff; Devon Check; Megan Bannon; Laura C Hanson; James Nicholas Dionne-Odom; Jennifer Corbelli; Michele Klein-Fedyshin; Yael Schenker; Camilla Zimmermann; Robert M Arnold; Dio Kavalieratos Journal: J Palliat Med Date: 2019-10-23 Impact factor: 2.947
Authors: Ryan D Nipp; Anne C Kirchhoff; Douglas Fair; Julia Rabin; Kelly A Hyland; Karen Kuhlthau; Giselle K Perez; Leslie L Robison; Gregory T Armstrong; Paul C Nathan; Kevin C Oeffinger; Wendy M Leisenring; Elyse R Park Journal: J Clin Oncol Date: 2017-08-17 Impact factor: 44.544
Authors: J C Kuo; D M Graham; A Salvarrey; F Kassam; L W Le; F A Shepherd; R Burkes; P J Hollen; R J Gralla; N B Leighl Journal: Curr Oncol Date: 2020-05-01 Impact factor: 3.677
Authors: Maria-Eleni Roumelioti; Jennifer L Steel; Jonathan Yabes; Kevin E Vowles; Yoram Vodovotz; Scott Beach; Bruce Rollman; Steven D Weisbord; Mark L Unruh; Manisha Jhamb Journal: Contemp Clin Trials Date: 2018-09-09 Impact factor: 2.226